Fractionated Laser Resurfacing for Actinic Keratoses and Skin Cancer Prevention
This study is investigating if Fractionated Laser Resurfacing (FLR), a rejuvenating laser that makes tiny holes in the skin, can prevent precancerous growths called actinic keratoses (AKs) and non-melanoma skin cancers. Researchers want to see if treating one forearm/wrist with FLR can protect it from these skin conditions in older adults. You might be able to join if you are 60 or older, have fair skin, and have 5 to 10 AKs on each forearm/wrist. The study will measure changes in the number of AKs and skin cancers over up to 5 years. The study is also exploring if photographs can predict where AKs and skin cancers will form. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 80 participants. It is testing Fractionated Laser Resurfacing.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for changes in actinic keratosis and non-melanoma skin cancers for up to 5 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Preventive Role of Fractionated Laser Resurfacing Against Actinic Neoplasia in an At-Risk Geriatric Population
At a glance
Conditions
NCT06428721
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Wright State Physicians
Fairborn, Ohiostudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Jeffrey Travers, MD, PhD · PRINCIPAL_INVESTIGATOR · Wright State University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Change from baseline in the number of actinic keratosis due to FLR treatment.Up to 5 years
Investigator will assess the number of actinic keratosis on both forearms at each visit.
- Change from baseline in the number of non-melanoma skin cancers due to FLR treatment.Up to 5 years
Investigator will assess the number of actinic keratosis on both forearms at each visit.